50 related articles for article (PubMed ID: 17362916)
1. Effect of sildenafil citrate on interleukin-1beta-induced nitric oxide synthesis and iNOS expression in SW982 cells.
Kim KO; Park SY; Han CW; Chung HK; Yoo DH; Han JS
Exp Mol Med; 2008 Jun; 40(3):286-93. PubMed ID: 18587266
[TBL] [Abstract][Full Text] [Related]
2. Febrigenic signaling to the brain does not involve nitric oxide.
Steiner AA; Rudaya AY; Ivanov AI; Romanovsky AA
Br J Pharmacol; 2004 Apr; 141(7):1204-13. PubMed ID: 15006900
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of gastric acid secretion by stress: a protective reflex mediated by cerebral nitric oxide.
Esplugues JV; Barrachina MD; Beltrán B; Calatayud S; Whittle BJ; Moncada S
Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14839-44. PubMed ID: 8962142
[TBL] [Abstract][Full Text] [Related]
4. Mesenteric lymph flow in adult and aged rats.
Akl TJ; Nagai T; Coté GL; Gashev AA
Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H1828-40. PubMed ID: 21873496
[TBL] [Abstract][Full Text] [Related]
5. The Effects of Different Doses of Sildenafil on Coronary Blood Flow and Oxidative Stress in Isolated Rat Hearts.
Banjac N; Vasović V; Stilinović N; Tomas A; Vasović L; Martić N; Prodanović D; Jakovljević V
Pharmaceuticals (Basel); 2023 Jan; 16(1):. PubMed ID: 36678615
[TBL] [Abstract][Full Text] [Related]
6. An Overview of NO Signaling Pathways in Aging.
Pourbagher-Shahri AM; Farkhondeh T; Talebi M; Kopustinskiene DM; Samarghandian S; Bernatoniene J
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361685
[TBL] [Abstract][Full Text] [Related]
7. Development of novel phosphodiesterase 5 inhibitors for the therapy of Alzheimer's disease.
Zuccarello E; Acquarone E; Calcagno E; Argyrousi EK; Deng SX; Landry DW; Arancio O; Fiorito J
Biochem Pharmacol; 2020 Jun; 176():113818. PubMed ID: 31978378
[TBL] [Abstract][Full Text] [Related]
8. PDE5 Exists in Human Neurons and is a Viable Therapeutic Target for Neurologic Disease.
Teich AF; Sakurai M; Patel M; Holman C; Saeed F; Fiorito J; Arancio O
J Alzheimers Dis; 2016; 52(1):295-302. PubMed ID: 26967220
[TBL] [Abstract][Full Text] [Related]
9. Possible overlapping time frames of acquisition and consolidation phases in object memory processes: a pharmacological approach.
Akkerman S; Blokland A; Prickaerts J
Learn Mem; 2016 Jan; 23(1):29-37. PubMed ID: 26670184
[TBL] [Abstract][Full Text] [Related]
10. Modulation of excitatory neurotransmission by neuronal/glial signalling molecules: interplay between purinergic and glutamatergic systems.
Köles L; Kató E; Hanuska A; Zádori ZS; Al-Khrasani M; Zelles T; Rubini P; Illes P
Purinergic Signal; 2016 Mar; 12(1):1-24. PubMed ID: 26542977
[TBL] [Abstract][Full Text] [Related]
11. Rivastigmine but not vardenafil reverses cannabis-induced impairment of verbal memory in healthy humans.
Theunissen EL; Heckman P; de Sousa Fernandes Perna EB; Kuypers KP; Sambeth A; Blokland A; Prickaerts J; Toennes SW; Ramaekers JG
Psychopharmacology (Berl); 2015 Jan; 232(2):343-53. PubMed ID: 24998257
[TBL] [Abstract][Full Text] [Related]
12. Improved long-term memory via enhancing cGMP-PKG signaling requires cAMP-PKA signaling.
Bollen E; Puzzo D; Rutten K; Privitera L; De Vry J; Vanmierlo T; Kenis G; Palmeri A; D'Hooge R; Balschun D; Steinbusch HM; Blokland A; Prickaerts J
Neuropsychopharmacology; 2014 Oct; 39(11):2497-505. PubMed ID: 24813825
[TBL] [Abstract][Full Text] [Related]
13. The PDE5 inhibitor vardenafil does not affect auditory sensory gating in rats and humans.
Reneerkens OA; Sambeth A; Van Duinen MA; Blokland A; Steinbusch HW; Prickaerts J
Psychopharmacology (Berl); 2013 Jan; 225(2):303-12. PubMed ID: 22855271
[TBL] [Abstract][Full Text] [Related]
14. Sildenafil restores cognitive function without affecting β-amyloid burden in a mouse model of Alzheimer's disease.
Cuadrado-Tejedor M; Hervias I; Ricobaraza A; Puerta E; Pérez-Roldán JM; García-Barroso C; Franco R; Aguirre N; García-Osta A
Br J Pharmacol; 2011 Dec; 164(8):2029-41. PubMed ID: 21627640
[TBL] [Abstract][Full Text] [Related]
15. A placebo-controlled study of sildenafil effects on cognition in schizophrenia.
Goff DC; Cather C; Freudenreich O; Henderson DC; Evins AE; Culhane MA; Walsh JP
Psychopharmacology (Berl); 2009 Jan; 202(1-3):411-7. PubMed ID: 18716761
[TBL] [Abstract][Full Text] [Related]
16. Selective phosphodiesterase inhibitors: a promising target for cognition enhancement.
Reneerkens OA; Rutten K; Steinbusch HW; Blokland A; Prickaerts J
Psychopharmacology (Berl); 2009 Jan; 202(1-3):419-43. PubMed ID: 18709359
[TBL] [Abstract][Full Text] [Related]
17. Sildenafil citrate attenuates a complex maze impairment induced by intracerebroventricular infusion of the NOS inhibitor Nomega-nitro-L-arginine methyl ester.
Devan BD; Pistell PJ; Daffin LW; Nelson CM; Duffy KB; Bowker JL; Bharati IS; Sierra-Mercado D; Spangler EL; Ingram DK
Eur J Pharmacol; 2007 Jun; 563(1-3):134-40. PubMed ID: 17362916
[TBL] [Abstract][Full Text] [Related]
18. Phosphodiesterase inhibition by sildenafil citrate attenuates a maze learning impairment in rats induced by nitric oxide synthase inhibition.
Devan BD; Bowker JL; Duffy KB; Bharati IS; Jimenez M; Sierra-Mercado D; Nelson CM; Spangler EL; Ingram DK
Psychopharmacology (Berl); 2006 Jan; 183(4):439-45. PubMed ID: 16320087
[TBL] [Abstract][Full Text] [Related]
19. Phosphodiesterase inhibition by sildenafil citrate attenuates the learning impairment induced by blockade of cholinergic muscarinic receptors in rats.
Devan BD; Sierra-Mercado D; Jimenez M; Bowker JL; Duffy KB; Spangler EL; Ingram DK
Pharmacol Biochem Behav; 2004 Dec; 79(4):691-9. PubMed ID: 15582676
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
